Autopsy report · NCT02979093

Oxytocin and Brain Responses in Maternal Addiction

“Unable to recruit proposed study sample size due to COVID restrictions.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 4 years before it stopped.
• 59 participants enrolled.
• Results were posted on the registry 3 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Lane Strathearn, MBBS PhD

Sponsor type

University, hospital or other

Conditions

Maternal Behavior; Maternal Addiction

Interventions

Oxytocin; Placebos; Functional MRI scanning

Participants

59

Sites

2

Countries

United States

Trials that died the same way

• Hypertonic Versus Isotonic Saline Irrigations for Chronic Rhinosinusitis
  “COVID-19 pandemic, unable to recruit and conduct study procedures per state, local, and university policies.” (76% match in meaning)
• Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil
  “Unable to recruit sufficient sample for study completion.” (75% match in meaning)
• Transgender Therapeutic Support Groups
  “Study unable to be conducted due to COVID.” (73% match in meaning)
• Narrative Exposure Therapy for Adults With Intellectual Disability
  “The study is no longer feasible due to the restrictions placed on access to potential participants during the COVID-19 pandemic.” (69% match in meaning)
• Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
  “Low rate of patient recruitment. Cannot achieve sample size.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.